There Is No Age Limit in the Fight for Health

This week the United Nations is bringing together world leaders to discuss the global health crisis of non-communicable diseases (NCDs): strokes, cancer, heart attacks, lung disease and dementia (Report, 17 September). These diseases are on the rise like never before: by 2030, the World Health Organisation (WHO) predicts that the top four killers in the world will be NCDs. What is most striking is that their impact is felt most on those over the age of 60, yet the emphasis of the summit is clearly on younger people. According to the WHO’s own statistics, 75% of deaths from NCDs globally occur in people aged 60 and over – an estimated 27 million people. Population ageing, as well as lifestyle factors, is inextricably linked to this global challenge.

The rise of NCDs is not a problem isolated to wealthier countries. According to some estimates, the over-60 population in developing countries is increasing 3% per year (compared to 2% in developed countries) and will grow from 473 million people in 2009 to 1.6 billion in 2050.

An ageing population brings a new set of critical health challenges. Alzheimer’s disease and other dementias, for example, affect 12% of those over 65 and more than 30% of those over 85. Over the next two decades, the number of people aged 65 and older suffering from diabetes is expected to increase by 134%. And then there’s cancer, which, according to one British study, is six times more likely to affect women aged 60 to 64 than women aged 35 to 38.

To win the fight against NCDs, governments and stakeholders must come together to create solutions that are appropriate for people of all ages, with no age limits being set for good health.

 

Source: The Guardian

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Joe Biden’s ‘Cancer Moonshot’ May be Derailed by New Policies, Including His Own

For almost a decade, President Biden has championed a bold “cancer moonshot” — an initiative he first launched in 2016, revived early in his administration, and reiterated during this year’s State of the Union. It is a laudable goal, especially for an aging nation where cancer and chronic disease are on the rise. There’s just one problem: Recent federal and state policies are poised to derail the incredible progress made in oncology since 2016. A rash of policies now threatens to limit access and slow progress towards new breakthroughs.

Global Coalition on Aging, Leading G7 Government Officials, Call for Incentivized Antibiotic Innovation

The Global Coalition on Aging (GCOA), in partnership with the Japanese Pharmaceutical Manufacturer’s Association (JPMA), and public health leaders call on G7 governments to fund pull incentives and make “fair share” investments in antibiotic innovation to fight the global antimicrobial resistance (AMR) crisis. GCOA, JPMA, and health and government officials from the European Union, Italy, Japan, and United Kingdom recently convened to discuss how G7 countries must respond. GCOA today published a report detailing takeaways from the closed-door meeting, “The Role of G7 Governments in Global Efforts to Encourage Antimicrobial Development Through a Pull Incentive: Challenges and Collaboration.”

Kishida and Biden Face a Similar Demographic Crisis

Your front page story “Japan wrestles with age-old problem as population declines at record rate” (Report, April 13) and the letter in the same edition from Tim Hill, “A gently declining population is no reason to panic”, both describe what all societies face as they modernise in the 21st century.

2024 AMR Preparedness Index Progress Report Highlights Urgent Need For Global Action Against Antimicrobial Resistance

Today, the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the 2024 AMR Preparedness Index Progress Report. Released in the lead up to the United Nations General Assembly 2024 High-level Meeting on Antimicrobial Resistance (AMR) this September, the 2024 Progress Report assesses how the eleven largest global economies have advanced on calls to action laid out in the 2021 AMR Preparedness Index.

New Global Analysis Across Five Cities Shows Inequities in Adult Immunization Uptake, Signaling Need to Redesign Local and National Policy Interventions

GSK, in collaboration with the Global Coalition on Aging (GCOA), announced a new report from the IQVIA Institute for Human Data Science (IQVIA Institute). The report, funded by GSK, explores the role of social and structural determinants of health in adult vaccine access and uptake across five global cities with strong data about their aging populations: Bangkok, Thailand; Brussels, Belgium; Chicago, US; Manchester, United Kingdom; and New York City, US.

New Report From the Global Coalition on Aging Highlights the Connection Between Adult Immunization and Economic Health in Aging APEC Region

As leaders from across the Asia-Pacific Economic Cooperation (APEC) region convene in San Francisco over the next week, a new report from the Global Coalition on Aging (GCOA) points to investments in healthy aging as a growing economic imperative amid the region’s changing demographics. According to the new report, programs that keep populations healthy, active, and productive – like adult immunization – are increasingly becoming a prerequisite for economic stability and growth.